Status
Conditions
Treatments
About
The aim of this study is to clinically compare the post-operative pain level and antibacterial effect when using the Diclofenac Potassium Insitu gel versus calcium hydroxide as an intra- canal medication in patients with apical periodontitis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Medically compromised patients having significant systemic disorders. (ASA III or IV).
Association with swelling or fistulous tract.
Acute or chronic peri-apical abscess. Mobility Grade II or III.
Pocket depth more than 5mm.
Previous root canal therapy.
Non-restorability
Patients with a contraindication for the use of DFK or those known to be allergic to any of the study medications.eg. Patient with kidney problems.
Primary purpose
Allocation
Interventional model
Masking
44 participants in 2 patient groups
Loading...
Central trial contact
Heba El Far, Professor; Dina Morsy, doctorate
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal